Skip to main content
Contact Us
Subscribe
E-Edition
37°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Certara, Inc. - Common Stock
(NQ:
CERT
)
14.19
-0.06 (-0.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Certara, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 14, 2025
Via
Benzinga
Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences
January 29, 2025
From
Certara
Via
GlobeNewswire
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
January 15, 2025
From
Certara
Via
GlobeNewswire
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 02, 2025
From
Certara
Via
GlobeNewswire
Forecasting The Future: 4 Analyst Projections For Certara
November 07, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
October 15, 2024
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Certara Stock
September 27, 2024
Via
Benzinga
Certara Showcases 2024 Research Wins With Over 100 Papers Published
December 02, 2024
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list
From
Certara
Via
GlobeNewswire
Certara Reports Third Quarter 2024 Financial Results
November 06, 2024
Updates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Participate in the Stephens Annual Investment Conference
October 28, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024
From
Certara
Via
GlobeNewswire
MaxCyte Appoints Cynthia Collins to its Board of Directors
October 15, 2024
From
MaxCyte, Inc
Via
GlobeNewswire
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
October 09, 2024
From
Certara
Via
GlobeNewswire
Certara Completes Acquisition of Chemaxon
October 02, 2024
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through...
From
Certara
Via
GlobeNewswire
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
September 27, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 27, 2024
Via
Benzinga
Certara’s Simcyp Consortium Celebrates 25th Anniversary
September 24, 2024
The pre-competitive scientific research consortium of top pharmaceutical companies remains a critical force in advancing qualified PBPK modeling and simulation to further drug development and...
From
Certara
Via
GlobeNewswire
Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug
September 18, 2024
Preclinical research on the trispecific antibody, ISB 2001, published in Nature Cancer leveraged virtual trials to select a higher starting dose that would lower costs and reduce cycle times
From
Certara
Via
GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
August 21, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software
August 15, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Misses EPS, Misses Revenue for Q2 2024
August 06, 2024
CERT stock results show that Certara missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Certara Reports Second Quarter 2024 Financial Results
August 06, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio
July 09, 2024
From
Certara
Via
GlobeNewswire
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024
July 02, 2024
From
Certara
Via
GlobeNewswire
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
June 17, 2024
AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies
From
Certara
Via
GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
May 29, 2024
From
Certara
Via
GlobeNewswire
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024
From
Certara
Via
GlobeNewswire
CERT Stock Earnings: Certara Meets EPS, Beats Revenue for Q1 2024
May 07, 2024
CERT stock results show that Certara met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Certara Reports First Quarter 2024 Financial Results
May 07, 2024
Reiterates Full Year 2024 Financial Guidance
From
Certara
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
